Patrick Yung Wen

57PUBLICATIONS
505CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Biological adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (57)

|Oct 06, 2026
Neoadjuvant PD1 plus CTLA-4 immune checkpoint blockade in surgically resectable recurrent glioblastoma: a randomized surgical window-of-opportunity trial.

|Aug 19, 2026
Exploring the landscape of targetable alterations in patients with glioblastoma.

|Aug 05, 2026
Vorasidenib improves response to subsequent chemoradiation in a genetically engineered mouse model of IDH-mutant glioma.

|Jul 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trial.

|Jun 03, 2026
Tumor transcriptional state predicts survival in immune-checkpoint-blockade-treated glioblastoma.

|May 22, 2026
Treatment Effect Reanalysis of the Randomized Individual Screening Trial of Innovative Glioblastoma Therapy in Newly Diagnosed Glioblastoma With External Control Data.

Pageof 10

Frequent Collaborators

17 joint publications

David Reardon

14 joint publications

Michael Weller

13 joint publications

Timothy F Cloughesy

12 joint publications

Keith L Ligon